Other Clinical Trial - A Study to Compare the Pharmacokinetics & Safety of

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

An open-label, randomized, single-dose, 2X3X3 partial replicate, crossover study to compare the pharmacokinetics and safety between a fixed dose combination of Fimasartan/Amlodipine/Rosuvastatin and Co-administration of a fixed dose combination of Fimasartan/Amlodipine and Rosuvastatin in healthy male subjects.

See also
Status	Clinical Trial	Phase
Completed	`NCT01918709` - Drug Interaction and Safety Between Valsartan and Rosuvastatin in Healthy Male Volunteers	Phase 1
Completed	`NCT03847506` - Evaluate Efficacy and Safety of Ezetimibe/Rosuvastatin and Candesartan Cilexetil/Amlodipine Besylate Combination Tablets	Phase 4
Completed	`NCT02994745` - A Clinical Trial to Evaluate the Pharmacokinetics and Safety/Tolerability of Fimasartan and Atorvastatin in Healthy Male Volunteers.	Phase 1

NCT number	NCT02995720
Study type	Interventional
Source	Boryung Pharmaceutical Co., Ltd
Contact
Status	Completed
Phase	Phase 1
Start date	August 26, 2016
Completion date	May 30, 2017

A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/Rosuvastatin

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms